Back
AbbVie Quote, Financials, Valuation and Earnings
Sponsored
ABBV
Sponsored
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Sell
40
ABBV
AbbVie
Last Price:
159.59
Seasonality Move:
2.71%
7 Day Trial
ALL ACCESS PASS
$
7
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.AbbVie Price Quote
$159.59
-0.03 (-4.6%)
(Updated: April 27, 2024 at 5:51 AM ET)
AbbVie Key Stats
Sell
40
AbbVie (ABBV)
is a Sell
Day range:
$157.65 - $167.46
52-week range:
$130.96 - $182.89
Dividend yield:
3.8%
P/E ratio:
58.68
P/S ratio:
5.21
P/B ratio:
27.22%
Volume:
10.6M
Avg. volume:
6.1M
1-year change:
-1.35%
Market cap:
$282B
Revenue:
$54.3B
EPS:
$2.73
How Much Does AbbVie Make?
Is AbbVie Growing As A Company?
AbbVie Stock Price Performance
What Is AbbVie 52-Week High & Low?
AbbVie Price To Free Cash Flow
-
Is AbbVie Stock Overvalued?
AbbVie is trading at a price to free cash flow ratio of 12.83 -
Is AbbVie Stock Undervalued?
AbbVie EV to Free Cash Flow ratio is 14.89 -
What Is AbbVie’s Price Earnings Growth Ratio?
ABBV PEG ratio is 0.00 -
Is AbbVie Trading At A Premium To Earnings?
AbbVie EV to EBIT ratio is 38.77
Is It Risky To Buy AbbVie?
Is AbbVie Cash Flow Positive?
AbbVie Return On Invested Capital
AbbVie Earnings Date & Stock Price
-
What Is AbbVie's Stock Price Today?
A single share of ABBV can be purchased today for 159.62 -
What Is AbbVie’s Stock Symbol?
AbbVie trades on the S&P500 under the ticker symbol: ABBV -
When Is AbbVie’s Next Earnings Date?
The next quarterly earnings date for AbbVie is scheduled on July 26, 2024 -
When Is ABBV's next ex-dividend date?
AbbVie's next ex-dividend date is April 12, 2024 -
How To Buy AbbVie Stock?
You can buy AbbVie shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
AbbVie Competitors
AbbVie Dividend Yield
AbbVie Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -66.67% | 2.18% |
Revenue: | -5.42% | 3.14% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 13 |
Sell Recommendations: | 0 |
Price Target: | 183.73 |
Upside from Last Price: | 15.1% |